Global Bioburden Testing Market will be worth USD 907.4 Million by 2024 – New market reports by Data Bridge Market Research

“Global bioburden testing market is expected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024”
Global Bioburden Testing Market, By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables ,By Technology, By Application, By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Industry Trends and Forecast to 2024

Global bioburden testing market is expected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The global bioburden testing market is segmented on the basis of test type, product type, technology, application, end-user, and geography.

For Sample Report: https://databridgemarketresearch.com/reports/bioburden-testing-market-industry-trends-and-forecast-to-2024/

On the basis of test type the bioburden testing market is segmented into aerobic, anaerobic, fungi and spore count.

On the basis of product type into instruments and consumable.

On the basis of technology microbial filter method, advanced colorimetric method and plate count method. The plate count method and membrane filtration method can be used to analyze the number of microbes in sample; the sample is passing through a filter with a pore size of 0.45 micrometers or less.

To read more about the scope and findings of this report visit: https://databridgemarketresearch.com/bioburden-testing-market-poised-grow-9-1/

On the basis of geography the market is segmented into 5 geographical regions, North America, South America, Europe, Asia-Pacific and Middle East and Africa. The regions are further segmented into 15 chief countries such as US, Mexico, Canada, India, China, Japan, Korea, Southeast Asia, and Brazil. In 2017, North America is expected to dominate the bioburden testing market with 57.6% market share followed by Europe and APAC. However the APAC region is expected to grow at the highest CAGR of 17.4% in the forecast period 2017 to 2024.

Global players operating in this market are  Charles River Laboratories International, Inc., Pacific Bio labs, Inc., Sigma-Aldrich Corporation, SGS S.A., WuXi PharmaTech Inc., Becton, Dickinson and Company, Merck & Co., Inc., Charles River Laboratories International Inc., North American Science Associates, Inc. (NAMSA), Nelson Laboratories, Inc., Dynatec Labs, and ATS Labs, Inc. among others.Tech Ltd., Tonic fitness Technology.

making process.

Related Reports:

https://databridgemarketresearch.com/reports/europe-radio-immunoassay-ria-reagents-and-devices-market/

By Product Type (Kit, Analyzer), By End User (Hospitals, Lab, Others), By Application (Diagnostic, Research) By Country (Germany, France, U.K., Spain, Italy, Russia, Turkey, Switzerland, Belgium, Netherlands, Rest of Europe)

 

Media Contact
Company Name: Data Bridge Market Research
Contact Person: Ravi Dubey
Email: ravi.dubey@databridgemarketresearch.com
Phone: +1-888-387-2818
Address:Office Number 317, Amanora Chambers, Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://databridgemarketresearch.com/reports/fitness-equipment-market-trends-forecast-2024/